Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Obesity Treatment Foundation | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their diet and activity via smartphone applications as compared with conventional in-person weight management programs.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Smart Technology Group | Experimental | The Smart Technology Group will receive a technology-based lifestyle intervention program which uses wearable technology, smartscales and smartphone applications to track and deliver feedback on caloric expenditure, physical activity, caloric intake and body weight. Participants will receive information through smartphone applications on strategies to make changes to their diet, physical activity, and weight-related behaviors along with standard 3 monthly in-person weight management visits. |
|
| Standard Weight Management Group | Other | The Standard Weight Management Group will receive 3 monthly in-person weight management visits during which they will receive standard of care lifestyle recommendations in accordance with the 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Wearable technology, smartscale | Device |
| ||
| Smartphone applications |
| Measure | Description | Time Frame |
|---|---|---|
| Change in body weight in kg | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline blood pressure | 6 months | |
| Change from baseline waist circumference | 6 months | |
| Change from baseline insulin resistance by homeostasis model assessment (HOMA-IR) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cherie Vaz, MD Dipl ABOM | Temple University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Temple University | Philadelphia | Pennsylvania | 19140 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jul 27, 2022 | |
| Reset | Aug 24, 2022 | |
| Release | Mar 31, 2026 | |
| Reset | Apr 21, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jul 27, 2022 | Aug 24, 2022 | |||
| Mar 31, 2026 |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D011236 | Prediabetic State |
| D015431 | Weight Loss |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
| ID | Term |
|---|---|
| D000076251 | Wearable Electronic Devices |
| ID | Term |
|---|---|
| D055615 | Electrical Equipment and Supplies |
| D004864 | Equipment and Supplies |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
|
| Standard Weight Management Visits | Behavioral |
|
| 6 months |
| Change from baseline hemoglobin A1c | 6 months |
| Change from baseline plasma triglycerides | 6 months |
| Change from baseline body weight in kg | 3 months |
| Change from baseline body weight in kg | 12 months |
| Change from baseline blood pressure | 12 months |
| Change from baseline waist circumference | 12 months |
| Change in Quality of Life | SF36 Questionnaire in wait-listed control group after the intervention | 6 months after receiving the intervention |
| Change in insulin resistance by homeostasis model assessment (HOMA-IR) | Wait-listed control group | 12 months compared to baseline and 6 months after receiving the intervention |
| Change in hemoglobin A1c | Wait-listed control group | 12 months compared to baseline and 6 months after receiving the intervention and from baseline |
| Change in plasma triglycerides | Wait-listed control group | 12 months compared to baseline and 6 months after receiving the intervention |
| Apr 21, 2026 |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D001836 | Body Weight Changes |